PHAXIAM Therapeutics S.A. Overview

PHAXIAM Therapeutics S.A. Cost of Revenue

Cost of Revenue analysis for PHXM.

Quarterly Cost of Revenue

$469000.00

↓ 71.87% YoY

As of Dec 31, 2023

Annual Cost of Revenue (TTM)

$2.14M

Trailing 12 months ending Dec 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin